Histone deacetylase inhibitors in the treatment of hematological malignancies.
about
The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA MethylationComparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.Syntheses and discovery of a novel class of cinnamic hydroxamates as histone deacetylase inhibitors by multimodality molecular imaging in living subjects.HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockadeHistone deacetylase inhibitors in the treatment of cancer: overview and perspectives.Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers.HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphomaCombination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells.Megakaryocyte lineage development is controlled by modulation of protein acetylation.
P2860
Q26772035-9D5A2110-1483-4FC4-BA2C-3D78896D4DD5Q30886620-B01DB41B-A4EB-4BA0-B7E5-C34681DCC21EQ35044051-106A391B-29C9-4317-BEFF-81AFCD47B796Q36912547-487DA10A-DAF4-40B7-847F-98802EDCE4EDQ38031633-D6DE22A3-05B5-451A-B51E-9EFE07DA758EQ38459887-06659F17-CCE0-428C-AE59-ACC5D2CE3C00Q38918235-E206C105-9ECD-4AA7-97F8-7602A037766AQ39165456-472A5513-B6BF-4055-B9A0-F6241F6676D5Q52716487-1A57C197-35DA-4121-800C-2C082A4237DD
P2860
Histone deacetylase inhibitors in the treatment of hematological malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@en
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@nl
type
label
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@en
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@nl
prefLabel
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@en
Histone deacetylase inhibitors in the treatment of hematological malignancies.
@nl
P2093
P50
P1476
Histone deacetylase inhibitors in the treatment of hematological malignancies
@en
P2093
B Fontanella
P304
P356
10.2174/138955711795843347
P577
2011-06-01T00:00:00Z